Procalcitonin as a Predictor of Mortality in Burn Patients with Suspected Sepsis
- Author:
In KIM
1
;
Do hern KYM
Author Information
- Publication Type:ORIGINAL ARTICLE
- From:Journal of Korean Burn Society 2020;23(2):37-41
- CountryRepublic of Korea
- Language:English
-
Abstract:
Purpose:The purpose of this study was to investigate the usefulness of Procalcitonin (PCT) as a predictor of mortality in patients with burn sepsis, which is closely related to mortality.
Methods:A retrospective study was conducted on 912 PCT patients diagnosed with burn sepsis in patients who survived fluid resuscitation for at least 3 days, aged 18 years or older who were admitted to Burn Intensive Care Unit (BICU) of Hallym University Hangang Sacred Heart Hospital from January 2008 to December 2018.
Results:Compared with the surviving group, TBSA (31%:65%), Inhalation (59.66%:74.23%) and ABSI (8 points:12 points) were statistically significantly higher in the death group. Looking at the changes in PCT levels in each survival and death group from Week 1 to Week 4, there was a statistically significant difference in PCT levels in the survival and death groups each week (P＜0.001). Although there were statistical differences between the survival and death groups in each state (P＜0.001), there was no difference in PCT values for each state in both groups (P=0.090).
Conclusion:In burn patients suspected of sepsis, the use of PCT is useful for predicting survival and death. It is necessary to conduct research based on prospective study through systematization of measurement standards and data from multiple institutions to increase the utilization of PCT through research that complements the limitations.
